Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018642 · ClinicalTrials.gov registry record · NA
Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
NCT00018642 is a NA study that has completed, run by US Department of Veterans Affairs.
The verdict
NCT00018642, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this research study is to determine whether a new drug for schizophrenia is better for the maintenance treatment than a standard drugs currently prescribed. The new medication is called quetiapine and it will be compared with a standard medication called haloperidol decanoate. The study will determine if quetiapine causes fewer problems than haloperidol with side effects such as stiffness and restlessness and whether it costs the VA more or less to treat patients with quetiapine. In addition, blood samples will be collected every three months to determine if certain chemicals in the blood can influence the outcome of the subjects' illness.
Interventions
- DRUG quetiapine
- DRUG haloperidol decanoate
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-04 |
| Est. Completion | 2002-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00018642
The ClinicalTrials.gov registry entry for NCT00018642 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which quetiapine is the first listed.
NCT00018642 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00018642 about?
NCT00018642 is a clinical study titled "Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder". The purpose of this research study is to determine whether a new drug for schizophrenia is better for the maintenance treatment than a standard drugs currently prescribed. The new medication is called quetiapine and it will be compared with a standard medication called haloperidol decanoate. The stu...
What is the current status of trial NCT00018642?
This trial is currently completed. It is a NA study. The study started on 1997-04. Estimated completion is 2002-03.
What interventions are being tested in trial NCT00018642?
The interventions under investigation include: quetiapine (DRUG), haloperidol decanoate (DRUG).
Who is sponsoring clinical trial NCT00018642?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.